Novartis Investigative site

Trois-Rivières

0 studies enrolling now · 2 studies all time

What they study most

COPD, Non-Small Cell Lung Cancer

Studies at this site

• A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer — Stopped early
• Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) — Completed